The Online Investor
SYK Buyback image

Stryker Corporation Buyback

OLI recorded this information on 3/3/2015

Company: Stryker Corporation
Buyback: SYK buyback
$Amount Authorized: $2,000,000,000
Buyback Details: Stryker Corporation (NYSE:SYK) announced today that its Board of Directors has authorized a new $2 billion share repurchase program. The program is in addition to $583 million of existing authorization remaining under the Company's current share repurchase programs, bringing the Company's total share repurchase authorization to $2.583 billion.

Stryker is a medical technology company. Co. provides products and services in orthopaedics, medical and surgical, and neurotechnology and spine. Co.'s Orthopaedics products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries. Co.'s MedSurg products include surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices and other medical device products used in a range of medical specialties. Co.'s Neurotechnology and Spine products include neurosurgical, neurovascular, and spinal implant devices.

Stryker SEC Filing Email Alerts Service

Open the SYK Page at The Online Investor »

Company Name: 
Stryker Corp
Stock buyback: 
SYK buyback
Website: 
www.stryker.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding SYK: 
104
Total Market Value Held by ETFs: 
$8.84B
Total Market Capitalization: 
$91.37B
% of Market Cap. Held by ETFs: 
9.67%
 

Open the SYK Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.15 out of 4)
38th percentile
(ranked lower than approx. 62% of all stocks covered)

Analysts' Target Price:
SYK Stock Forecast

Based on Zacks ABR data;
powered by Xignite

SYK Buyback Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.